BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 37970927)

  • 1. [Actitudes e imágenes sociales sobre el cribado de cáncer colorrectal. Una aproximación exploratoria mediante grupos de discusión.].
    de Haro Gázquez D; Fernández Sánchez B; Amador Muñoz ML
    Rev Esp Salud Publica; 2023 Aug; 97():. PubMed ID: 37970927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Favorable Survival After Screening for Young-Onset Colorectal Cancer: Benefits of Screening in Young Adults.
    Takada K; Hotta K; Imai K; Ito S; Kishida Y; Ono H
    Dis Colon Rectum; 2022 Aug; 65(8):996-1004. PubMed ID: 34856591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Main results of the colorectal cancer screening program in the Basque Country (Spain)].
    Portillo I; Idígoras I; Ojembarrena E; Arana-Arri E; Zubero MB; Pijoán JI; López Urrutia A; Marqués ML
    Gac Sanit; 2013; 27(4):358-61. PubMed ID: 23416028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Results of National Colorectal Cancer Screening Program in Croatia (2007-2011).
    Katičić M; Antoljak N; Kujundžić M; Stamenić V; Skoko Poljak D; Kramarić D; Stimac D; Strnad Pešikan M; Samija M; Ebling Z
    World J Gastroenterol; 2012 Aug; 18(32):4300-7. PubMed ID: 22969192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Faecal occult blood testing (FOBT)-based colorectal cancer screening trends and predictors of non-use: findings from the South Australian setting and implications for increasing FOBT uptake.
    Todorov K; Wilson C; Sharplin G; Corsini N
    Aust Health Rev; 2018 Feb; 42(1):45-52. PubMed ID: 28248632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved Survival in a Cohort of Patients Aged 75 Years and Older With Fecal Immunochemical Testing-Detected Colorectal Cancer.
    Cahill C; Lipson ME; Afzal AR; Maclean AR; Wong CK; Roen S; Buie WD
    Dis Colon Rectum; 2023 Apr; 66(4):511-520. PubMed ID: 35764093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Geographic variation in compliance with Australian colorectal cancer screening programs: the role of attitudinal and cognitive traits.
    Goodwin BC; March S; Ireland M; Crawford Williams F; Manksi D; Ford M; Dunn J
    Rural Remote Health; 2019 Jul; 19(3):4957. PubMed ID: 31340653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Lesions Detected in Six Spanish Colorectal Cancer Screening Population Based Programmes. CRIBEA Project. Spain].
    Portillo Villares I; Arana-Arri E; Idigoras Rubio I; Espinás Piñol JA; Pérez Riquelme F; de la Vega Prieto M; González Aledo A; Oceja Setien E; Vanaclocha Espi M; Ibáñez Cabanell J; Salas Trejo D;
    Rev Esp Salud Publica; 2017 Feb; 91():. PubMed ID: 28218734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations of Race, Ethnicity, and Social Determinants of Health With Colorectal Cancer Screening.
    Kane WJ; Fleming MA; Lynch KT; Friel CM; Williams MD; Hedrick TL; Yan G; Hoang SC
    Dis Colon Rectum; 2023 Sep; 66(9):1223-1233. PubMed ID: 35533321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends and inequities in colorectal cancer screening participation in Ontario, Canada, 2005-2011.
    Honein-AbouHaidar GN; Baxter NN; Moineddin R; Urbach DR; Rabeneck L; Bierman AS
    Cancer Epidemiol; 2013 Dec; 37(6):946-56. PubMed ID: 23702337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of Colorectal Cancer and Advanced Polyps One Year After Excision of High-Risk Adenomas.
    Medina-Prado L; Mangas-Sanjuan C; Baile-Maxía S; Martínez-Roca AA; Murcia Ó; Zarraquiños S; Rodríguez-Camacho E; Aginagalde AH; Álvarez-Urturi C; Valverde-Roig MJ; Zapater P; Bujanda L; Salas D; Portillo I; Pellisé M; Cubiella J; Jover R
    Dis Colon Rectum; 2022 Sep; 65(9):1112-1120. PubMed ID: 34840293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors influencing participation in colorectal cancer screening programs in Spain.
    Vanaclocha-Espi M; Ibáñez J; Molina-Barceló A; Pérez E; Nolasco A; Font R; Pérez-Riquelme F; de la Vega M; Arana-Arri E; Oceja M; Espinàs JA; Portillo I; Salas D;
    Prev Med; 2017 Dec; 105():190-196. PubMed ID: 28887191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repeated screening for colorectal cancer with fecal occult blood test in Catalonia, Spain.
    Garcia M; Borràs JM; Binefa G; Milà N; Espinàs JA; Moreno V
    Eur J Cancer Prev; 2012 Jan; 21(1):42-5. PubMed ID: 21849903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Colorectal Cancer Early Screening Program of Barcelona, Spain: Indicators of the first round of a program with participation of community pharmacies].
    Burón A; Grau J; Andreu M; Augé JM; Guayta-Escolies R; Barau M; Macià F; Castells A;
    Med Clin (Barc); 2015 Aug; 145(4):141-6. PubMed ID: 25073826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Social determinants and participation in fecal occult blood test based colorectal cancer screening: A qualitative systematic review and meta-synthesis.
    Marinucci N; Moy N; Koloski N; Shah A; Austin G; Russell-Bennett R; McGraw J; Dulleck U; Holtmann G
    Health Promot J Austr; 2024 Jan; 35(1):9-36. PubMed ID: 37039425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of social support and stressful life events on adherence to colorectal cancer screening using faecal occult blood test in Spanish medium risk population.
    Menéndez Rodríguez M; García-Morales N; Seoane Pillado T; Garau Ramírez J; Traver Salvador A; Hervás Jiménez Y; Fernández-Domínguez MJ; Menéndez Villalva C; Cubiella J
    Gastroenterol Hepatol; 2024 Jan; 47(1):14-23. PubMed ID: 36842551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Testing behavioral interventions to optimize participation in a population-based colorectal cancer screening program in Catalonia, Spain.
    Stoffel S; Benito L; Milà N; Travier N; Binefa G; Vidal C; Espinosa J; Moreno V; Garcia M
    Prev Med; 2019 Feb; 119():58-62. PubMed ID: 30594532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A qualitative evaluation of strategies to increase colorectal cancer screening uptake.
    Tinmouth J; Ritvo P; McGregor SE; Claus D; Pasut G; Myers RE; Guglietti C; Paszat LF; Hilsden RJ; Rabeneck L
    Can Fam Physician; 2011 Jan; 57(1):e7-15. PubMed ID: 21322288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Knowledge and attitude among general practitioners in Andalusia (Spain) on the identification of subjects at high risk of breast and colorectal cancer].
    Sánchez Pérez MR; Sánchez Pérez MJ; Lorente Acosta JA; Bayo Lozano E; Mancera Romero J
    Semergen; 2019; 45(1):6-14. PubMed ID: 30529356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Viewpoints of the target population regarding barriers and facilitators of colorectal cancer screening in the Czech Republic.
    Kroupa R; Ondrackova M; Kovalcikova P; Dastych M; Pavlik T; Kunovsky L; Dolina J
    World J Gastroenterol; 2019 Mar; 25(9):1132-1141. PubMed ID: 30863000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.